NEW YORK--(BUSINESS WIRE)-- Synergy Pharmaceuticals, Inc. (NASDAQ: SGYPD, SGYPU), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback